Clinical Trial Update: Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab with chemotherapy and radiotherapy in newly diagnosed metastatic nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Radiotherapy
• Sintilimab (sintilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN